Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

All-NBA, all vaccinated (?), and almost being done with the regular season with Kwani Lunis

All-NBA, all vaccinated (?), and almost being done with the regular season with Kwani Lunis

FromCeltics Lab NBA Basketball Podcast


All-NBA, all vaccinated (?), and almost being done with the regular season with Kwani Lunis

FromCeltics Lab NBA Basketball Podcast

ratings:
Length:
52 minutes
Released:
Apr 2, 2022
Format:
Podcast episode

Description

The Boston Celtics have at least one player likely to land on an All-NBA team for the 2021-22 season in All-Star forward Jayson Tatum, but due to his eligibility at both guard and forward for the honor (to say nothing of the positional flexibility afforded some stars but not others), it remains unclear whether the St. Louis native will end up with first, second, or third team honors.
Uncertainty also abounds in the team's media coverage with potential playoff eligibility in a series against the Toronto Raptors with speculation abounding regarding the vaccination status of all Celtics players in light of Toronto's vaccine mandate.
In this episode of the CLNS Media "Celtics Lab" podcast, we team up with "The A-List" podcast host and NBC 10 Boston broadcaster Kwani A. Lunis to talk through these forward-looking issues.
Join your usual hosts Cameron Tabatabaie, Alex Goldberg, and Justin Quinn as we do our best to suss out where Tatum (and the rest of the league's best players) should be honored by the league and more.
Support this podcast at — https://redcircle.com/celtics-lab-nba-basketball-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Apr 2, 2022
Format:
Podcast episode

Titles in the series (100)

On Celtics Lab, we go deep into the details, finding compelling narratives, data, stories and interviews you won't find anywhere else.